All In MedTech

FDA Clearance Tracker · K083199

CHARTIS CONSOLE

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 19, 2026Latest source record: Jun 25, 2009 (this decision)Source: openFDAMethods & limitations

510(k)

Decided

Jun 25, 2009

Substantially Equivalent

Time to decision

238 days

Received Oct 30, 2008. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K083199
Device name
CHARTIS CONSOLE
Applicant
Pulmonx, Inc.
Applicant location
Palo Alto, CA
Received
Oct 30, 2008
Decided
Jun 25, 2009
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 868.1840

Every decision under product code BZG

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code BZG. The earliest in FDA's data is K770927, decided May 26, 1977.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

  • FDA database record for K083199
  • The applicant filed a summary instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Pulmonx, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.